PAMORELIN

US serial number:85075562
Application filling date:Jul. 01, 2010
Register:Principal
Mark type:Trademark
Status:Registered. The registration date is used to determine when post-registration maintenance documents are due.
Status date:Aug. 30, 2011
Publication date:Jun. 14, 2011
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Foreign foreign registration number:448064
Foreign foreign registration date:Jul. 22, 1997
Foreign foreign application registration country:SWITZERLAND
Foreign foreign expiration date:Jul. 22, 2017
Goods and services:For: Pharmaceutical preparations, namely, chemiotherapeutical medicines and medicines that act on the endocrinal functions, hormones, and on metabolism for the treatment of prostate cancer, endometriosis, precocious puberty, breast cancer, in vitro fertil
Current owner owner name:DEBIOPHARM S.A.
Current owner owner address:CH. DE MESSIDOR 5-7 FORUM "APRES-DEMAIN" CP 5911 LAUSANNE SWITZERLAND 1002
Current owner legal entity type:CORPORATION
Current owner state or country:SWITZERLAND
Attorney name:Duane M. Byers
Attorney email:nixonptomail@nixonvan.com
Attorney docket number:2548-39-dmb
Attorney email authorized:No
Correspondent name address:DUANE M. BYERS NIXON & VANDERHYE, P.C. 901 N GLEBE RD FL 11 ARLINGTON, VIRGINIA UNITED STATES 22203-1853
Correspondent phone:7037867421
Correspondent email:nixonptomail@nixonvan.com
Correspondent fax:7038164100
Correspondent email authorized PAMORELIN:No

Reviews

Required fields are marked *